Rapid Micro Biosystems, Inc.
Market Cap
$129.42M
P/E Ratio
-2.78
EPS
$-1.05
Dividend Yield
0.00%
52-Week Range
$1.86 — $4.94
Volume
220.63K
Avg Volume
260.77K
Beta
1.39
P/E (TTM)
-2.78
Forward P/E
—
PEG Ratio
0.54
P/S (TTM)
4.52
P/B (TTM)
4.60
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.95%
ROA (TTM)
-0.63%
ROIC
—
Gross Margin
0.17%
Operating Margin
-1.41%
Net Margin
—
Debt/Equity
0.72
Current Ratio
3.31
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.17%
EPS Growth (5Y)
-0.26%
Sales Growth (3Y)
+0.10%
Sales Growth (5Y)
+0.14%
EPS Est (This Year)
$-0.88
EPS Est (Next Year)
$-0.72
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.86
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
44.32M
Float
19.05M
Free Float %
42.98%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2021-07-15
Employees
163
CEO
Robert G. Spignesi Jr.
Index Membership
—
Website
https://www.rapidmicrobio.com
Rapid Micro Biosystems, Inc. (RPID) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $129.42M, a P/E ratio of -2.78, RPID is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RPID against other stocks using dozens of fundamental and technical filters.
Rapid Micro Biosystems, Inc. (RPID) has a trailing twelve-month (TTM) P/E ratio of -2.78. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Rapid Micro Biosystems, Inc. (RPID) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Rapid Micro Biosystems, Inc. (RPID) has a market capitalization of $129.42 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.